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Abstract
Due to rapid technological advances, a wide range of different measurements can be
obtained from a given biological sample including single nucleotide polymorphisms, copy
number variation, gene expression levels, DNA methylation and proteomic profiles. Each
of these distinct measurements provides the means to characterize a certain aspect of
biological diversity, and a fundamental problem of broad interest concerns the discovery
of shared patterns of variation across different data types. Such data types are hetero-
geneous in the sense that they represent measurements taken at very different scales or
described by very different data structures. We propose a distance-based statistical test,
the generalized RV (GRV) test, to assess whether there is a common and non-random
pattern of variability between paired biological measurements obtained from the same
random sample. The measurements enter the test through distance measures which can
be chosen to capture particular aspects of the data. An approximate null distribution
is proposed to compute p-values in closed-form and without the need to perform costly
Monte Carlo permutation procedures. Compared to the classical Mantel test for associ-
ation between distance matrices, the GRV test has been found to be more powerful in a
number of simulation settings. We also report on an application of the GRV test to detect
biological pathways in which genetic variability is associated to variation in gene expres-
sion levels in ovarian cancer samples, and present results obtained from two independent
cohorts.
1 Introduction
A proliferation in the development and application of high-throughput measurement plat-
forms in biological research has resulted in the increasing availability of multiple levels of
molecular data available for the same biological sampling units. For a range of human tu-
mour types, for instance, the Cancer Genome Atlas (TCGA) consortium have made available
∗Corresponding author: g.montana@imperial.ac.uk
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genome-wide SNP genotypes, DNA copy number, genome-wide gene (and mRNA) expression,
DNA methylation and proteomic profiles, as well as a range of mutation calls arising from
deep sequencing. Such comprehensive molecular profiling of biological sampling unit provides
opportunities for gaining insight into the mechanisms by which different molecular entities
interact with one another to influence the overall state of the cell(s) in question. This is
possible through comparing the different types of observations on each biological sampling
unit, via some means of paired analysis of the individual datasets. A certain degree of com-
plexity is inherent in this type of analysis since the measurements that are being compared
are heterogeneous.
One well-studied example of the task of analysing paired heterogeneous biological data
is gene expression quantitative trait loci (eQTL) mapping, which seeks to find associations be-
tween single nucleotide polymorphisms (SNPs) and transcript expression levels (Cookson et al.,
2009). A particularly interesting application of multivariate eQTL mapping relates to the dis-
covery of association between biomarkers for ovarian cancer, which is treated as a case study
in this work.
The application of paired analysis of heterogeneous biological data types is not limited
to eQTL mapping, and involves the very common problem of discovering shared patterns of
variation across different biological measurements. Other areas that have seen considerable
interest include the association of genetic copy number variation with gene expression levels
(Beroukhim et al., 2007) and identification of genes for which DNA methylation is associated
to gene expression (Louhimo and Hautaniemi, 2011). In these and related studies, the prob-
lem of comparing heterogeneous data types can be approached using a notion of distance
between pairs of biological samples. Distances are scalar-valued measures of dissimilarity
between two input observations, with greater values indicating greater dissimilarity between
them. For a given application, a suitable semi-metric or metric distance measure can gen-
erally be defined depending on the nature of the data and on the specific objectives of the
study. Such distances computed between all pairwise combinations of samples are arranged
in square, symmetric matrices. These matrices then quantify the variability in the random
sample according to that particular distance measure, and can be directly compared using an
appropriate statistical test.
Distance-based approaches offer a number of advantages compared to direct comparisons
involving the original measurements. Firstly, distances can overcome limitations of traditional
multivariate approaches when dealing with high-dimensional random vectors observed on a
much smaller number of sampling units (Shannon et al., 2002). Secondly, distance measures
can be appropriately defined for data generated under different experimental conditions, and
are not confined to data types represented only by vectors. A number of distance measures
are readily available for several types of biological data, including DNA sequences (Wu et al.,
1997), genetic markers such as SNPs (Goh et al., 2011), gene expression data (Priness et al.,
2007), longitudinal gene expression data (Minas et al., 2011) and proteins (Hollich et al.,
2005). Moreover, for a specific data type, more than one distance measure can be deployed
to capture different aspects of the data. This can ultimately lead to the discovery of different
types of associations.
Only a handful of statistical procedures are currently available to determine whether there
is an association between paired distance matrices, and they all rely on computationally inten-
sive procedures for statistical inference. The most commonly used and well-known procedure
is the Mantel test (Mantel, 1967), a generalization of Pearson’s correlation. The test has al-
ready been found useful in many applications arising in bioinformatics (Shannon et al., 2002;
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Beckmann et al., 2005; Sun et al., 2011). This testing procedure, however, has some limita-
tions. First, when used to compare paired scalar-valued observations using the Euclidean dis-
tance, the test exhibits less power than a Pearson’s correlation test (Peres-Neto and Jackson,
2001; Legendre and Fortin, 2010). Secondly, computationally intensive Monte Carlo permu-
tations are required to assess significance. This procedure, which assumes exchangeability
of the sampling units under the null hypothesis of no association, introduces sampling er-
rors which leads to inaccurate estimation of small p-values. This is especially true when too
few permutations are used, generally between O(103) and O(105) (Berry and Mielke, 1983;
Mielke and Berry, 2007; Knijnenburg et al., 2009). For example, in order to obtain a permu-
tation p-value within 10−5 of the true p-value, it has been shown that O(107) permutations are
required, which is computationally infeasible without access to specialised high-performance
computational resources. This is the case in all situations where thousands or even millions
of tests are required, such as in eQTL mapping studies in which the entire genome is scanned
in search of potential associations. In such large-scale applications, it is not uncommon to
settle for a much smaller number of Monte Carlo permutations per test, which in turn can
lead to inflated family-wise type I error rates (Phipson and Smyth, 2010).
In this article we propose a novel test, the generalized RV (GRV) test, to detect association
between paired distance matrices. This test is derived as a generalization of the classical
multivariate RV test of no correlation between paired random vectors, originally proposed
by Escoufier (1973). While inference can be performed via computationally intensive Monte
Carlo permutations, we also derive an approximation to the exact null distribution which
would be obtained by enumerating all permutations. Using the proposed null distribution,
approximate p-values can be estimated in closed-form without the need for computationally
intensive procedures. The proposed GRV test is introduced in Section 2. In Section 3 we
describe power studies showing that the GRV test can offer greater statistical power than
that achieved by the Mantel test even when many millions of Monte Carlo permutations
are performed. Section 4 presents an application of the GRV test in cancer research, where
the interest lies in detecting biological pathways characterized by a non-random association
between genetic and gene expression sample variability. Concluding remarks are presented in
Section 5.
2 The generalized RV test
2.1 Problem statement
Assume we have observed paired measurements {(xi, yi)}Ni=1 on N independent biological
sampling units. Each one of the {xi}Ni=1 and {yi}Ni=1 measurement sets is represented by a
particular data structure, such as continuous or discrete vectors, although the data do not
necessarily need to be represented as vectors. For instance, the measurements might be struc-
tured as graphs or trees (e.g. representing biological networks or ontologies). We also suppose
that suitably chosen semi-metric or metric distances dx and dy have been identified that cap-
ture the dissimilarity between any sample pair {(xi, xj)}i 6=j and {(yi, yj)}i 6=j , respectively. On
evaluating the distances for all possible pairs, we obtain the paired N ×N distance matrices
∆x = {dx(xi, xj)}Ni,j=1 and ∆y = {dy(yi, yj)}Ni,j=1.
Using the random sample, evidence of non-random association between these paired ge-
nomic measurements can be assessed by testing the null hypothesis that ∆x 6= a∆y, for
some positive constant a. This constant represents possible scaling differences between the
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elements of each distance matrix, which may arise because of the chosen distance measures.
Under this null hypothesis, the relationship between the elements in ∆x is not maintained by
the corresponding elements in ∆y. The alternative hypothesis is that the distance matrices
are equal up to a constant, in which case every distance dx(xi, xj) is linearly related to the
paired distance dy(yi, yj). We are particularly concerned with settings where inferences must
be drawn for a very large number of such tests simultaneously, hence the computational cost
in obtaining a p-value for each test should be kept as low as possible.
2.2 The proposed test statistic
When the observations are vectorial, the mean-centered vectors {xi}Ni=1 ∈ RP and {yi}Ni=1 ∈
R
Q can be arranged in paired data matrices, X and Y , of dimensions N × P and N × Q,
respectively. In this case, in order to establish whether the P and Q variables are correlated,
the null hypothesis that Σxy = 0 is commonly tested, where Σxy is the P × Q covariance
matrix containing the true covariances between the P variables observed in {xi}Ni=1 and Q
variables observed in {yi}Ni=1. The RV statistic has been proposed for this task and arises as
a generalization of Pearson’s correlation (Escoufier, 1973). As with Pearson’s correlation, RV
is computed as the ratio of covariance to the square-rooted product of the variances,
RV(X,Y ) =
tr
(
XTY Y TX
)
||XTX||||Y TY || , (1)
where tr(·) is the trace function and ||A|| =
√
tr(ATA) denotes the Frobenius norm for matrix
A. The RV statistic ranges between 0 and 1, with no association whenXTY = 0, and perfect
association when there exists a linear mapping which relates every P -dimensional observation
in X to every Q-dimensional observation in Y . Thus larger values provide evidence against
the null hypothesis. When P = Q = 1, RV(X,Y ) = cor2(X,Y ), where cor(·, ·) denotes
Pearson’s correlation coefficient.
We first observe that the RV test can be interpreted in terms of the Euclidean distance ma-
trices ∆x and∆y arising by applying the Euclidean distance measure to {xi}Ni=1 and {yi}Ni=1,
respectively. This is because, due to properties of the trace operator, tr(XTY Y TX) =
tr(XXTY Y ), ||XTX|| = ||XXT || and ||Y TY || = ||Y Y T ||, so that RV statistic (1) can be
written in equivalent form as
RV(X,Y ) =
tr
(
XXTY Y T
)
||XXT ||||Y Y T || . (2)
Note that (1) differs from (2) in that emphasis is placed on the two symmetric N×N matrices
XXT and Y Y T , instead of the four covariance matrices XTY ∈ RP×Q, Y TX ∈ RQ×P ,
XTX ∈ RP×P and Y TY ∈ RQ×Q. In settings where P,Q > N , which are common when
comparing biological measurements, it is computationally convenient to use (2) over (1).
In addition, the N × N matrices XXT and Y Y T can each be written in terms of the
Euclidean distance matrices ∆x and ∆y, respectively. This is due to the results that
XXT = −1
2
C∆2xC and Y Y
T = −1
2
C∆2yC,
where C = (IN − JN/N) is the symmetric N ×N centering matrix where IN is the identity
matrix of sizeN and JN is the square matrix of ones of sizeN (Gower, 1966; Borg and Groenen,
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2005). Also, −1
2
C∆2xC = Gx, where Gx is the square, symmetric and real-valued Gower’s
centered inner product matrix, and similarly for Gy, so that tr
(
XXTY Y T
)
= tr (GxGy),
||XXT || = ||Gx|| and ||Y Y T || = ||Gy||. Thus RV is completely specified by the elements of
the Euclidean distance matrices.
Based on these observations, we propose a generalization for the RV statistic that is
entirely specified by any pair of distance matrices, not necessarily Euclidean, in order to test
the null hypothesis that ∆x 6= a∆y. The generalized RV (GRV) test statistic is defined as
GRV(Gx,Gy) =
tr (GxGy)
||Gx|| ||Gy|| , (3)
noting the implicit assumption ||Gx|| ||Gy|| > 0 which is always satisfied in practice; ||Gx|| > 0
since Gx contains real-valued elements which are not all zero, and similarly for Gy.
It is insightful to understand in which ways the proposed GRV statistic is similar to,
and differs from, the classical Mantel statistic. The Mantel statistic is computed as the
correlation between the upper-triangular distances of each distance matrix. Denote by vx
the column vector containing the A = N(N−1)/2 upper-triangular distances {dx(xi, xj)}i>j ,
and similarly for vy. The Mantel statistic is then computed as rM (∆x,∆y) = cor (vx,vy),
i.e.,
rM (∆x,∆y) =
1
A− 1
∑
i>j
(
dx(xi, xj)− x¯
sx
)(
dy(yi, yj)− y¯
sy
)
,
where x¯ =
∑
i>j dx(xi, xj)/A, s
2
x =
∑
i>j(dx(xi, xj)− x¯)2/(A− 1), and similarly for y¯ and s2y.
The statistic therefore standardizes the upper-triangular elements of each distance matrix to
have zero mean and unit variance. In this way the distances between paired distance matrices
can be directly compared.
It can be shown that, like Mantel, GRV is also a correlation coefficient. In particular, it can
be proved that GRV is equal to the correlation between the vectorized matrices Gx/||Gx|| and
Gy/||Gy||, i.e., the N2-dimensional vectors gx and gy with elements {gx(xi, xj)/||Gx||}Ni,j=1
and {gy(yi, yj)/||Gy||}Ni,j=1, respectively. That is, GRV(Gx,Gy) = cor (gx,gy) (see Appendix
A for a proof). While both Mantel and GRV are correlation coefficients, the difference
between them lies in the methods of standardization applied to the distances in each case.
In Mantel, the upper-triangular distances are subjected to a classical standardization, where
their mean is subtracted and they are divided by their standard deviation. In GRV, however,
all distance elements are considered, and they are squared, double-centered and normalized
by dividing by their Frobenius norm. This difference leads to greater power of the GRV test to
detect association between paired distance matrices than the Mantel test, as demonstrated in
Section 3. Further properties of the GRV test statistic are provided in Appendix B, including
a discussion of how it overcomes the limitation of Mantel for scalar-valued observations and
Euclidean distances.
2.3 Approximate null distribution
Under the null hypothesis, the sampling distribution of GRV is generally unknown. This is
because the quantity T = tr(GxGy) in the numerator is completely specified by the elements
of ∆x and ∆y, which have unknown distributions and are correlated. The null sampling
distribution can be generated by using permutations of one of the centered inner product
matrices, Gy, say. For each of Npi permutations pi ∈ Π, which are one-to-one mappings of the
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Table 1: Power of the GRV and Mantel tests at a significance level of 0.1% for N = {30, 50, 70, 90, 100} and all combinations of the genetic (gen)
identity-by-state (IBS), Sokal and Sneath (SS), and Rogers and Tanimoto I (RTI) distances and gene expression (gex) Euclidean (Euc), Manhattan
(Man) and Mahalanobis (Mah) distances. For the GRV test, the standard deviation of the power estimate is given in brackets. For the Mantel
test, the confidence interval obtained with 95% coverage probability is given in square brackets. The average number of Monte Carlo permutations
required to achieve the power estimates for Mantel are stated below the confidence interval in millions.
Gen Gex Test N
dist dist 30 50 70 90 100
IBS Euc GRV 0.126 (0.042) 0.351 (0.064) 0.566 (0.074) 0.712 (0.049) 0.780 (0.051)
Mantel 0.081 [0.042, 0.126] 0.116 [0.056, 0.183] 0.225 [0.145, 0.291] 0.275 [0.228, 0.325] 0.322 [0.272, 0.374]
3.081 1.575 9.921 13.51 19.61
Man GRV 0.139 (0.049) 0.375 (0.068) 0.590 (0.066) 0.730 (0.059) 0.772 (0.065)
Mantel 0.069 [0.023, 0.120] 0.151 [0.091, 0.226] 0.240 [0.173, 0.306] 0.302 [0.238, 0.355] 0.378 [0.314, 0.444]
1.859 2.134 6.290 13.80 8.794
Mah GRV 0.394 (0.061) 0.846 (0.047) 0.952 (0.030) 0.978 (0.020) 0.990 (0.014)
Mantel 0.100 [0.049, 0.169] 0.311 [0.262, 0.355] 0.542 [0.513, 0.572] 0.715 [0.694, 0.735] 0.776 [0.761, 0.789]
2.818 28.53 135.9 424.2 666.8
SS Euc GRV 0.038 (0.029) 0.157 (0.042) 0.299 (0.067) 0.470 (0.064) 0.556 (0.063)
Mantel 0.035 [0.006, 0.064] 0.111 [0.069, 0.154] 0.180 [0.112, 0.245] 0.268 [0.202, 0.329] 0.319 [0.254, 0.381]
0.971 5.318 3.032 7.445 10.69
Man GRV 0.045 (0.028) 0.160 (0.046) 0.308 (0.068) 0.503 (0.073) 0.556 (0.068)
Mantel 0.047 [0.018, 0.073] 0.121 [0.080, 0.171] 0.195 [0.133, 0.269] 0.310 [0.242, 0.387] 0.363 [0.290, 0.424]
2.879 10.27 4.371 7.325 9.232
Mah GRV 0.092 (0.041) 0.481 (0.074) 0.784 (0.059) 0.907 (0.037) 0.927 (0.034)
Mantel 0.072 [0.030, 0.112] 0.266 [0.194, 0.340] 0.510 [0.448, 0.564] 0.652 [0.613, 0.687] 0.723 [0.689, 0.756]
5.567 8.635 21.92 74.12 40.01
RTI Euc GRV 0.044 (0.027) 0.159 (0.047) 0.340 (0.062) 0.551 (0.067) 0.654 (0.063)
Mantel 0.032 [0.010, 0.065] 0.106 [0.061, 0.154] 0.205 [0.142, 0.265] 0.302 [0.233, 0.366] 0.339 [0.272, 0.397]
1.327 5.141 8.112 1.421 16.36
Man GRV 0.055 (0.035) 0.172 (0.052) 0.363 (0.067) 0.540 (0.076) 0.639 (0.072)
Mantel 0.051 [0.019, 0.089] 0.124 [0.067, 0.171] 0.216 [0.154, 0.288] 0.360 [0.282, 0.432] 0.401 [0.321, 0.465]
1.373 4.512 4.371 9.289 7.233
Mah GRV 0.173 (0.055) 0.675 (0.068) 0.925 (0.038) 0.987 (0.015) 0.993 (0.010)
Mantel 0.062 [0.011, 0.119] 0.241 [0.180, 0.314] 0.515 [0.478, 0.554] 0.688 [0.672, 0.702] 0.765 [0.755, 0.776]
0.8066 11.89 151.0 654.4 1068
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set {1, . . . , N} to itself, the rows and columns of Gy are simultaneously permuted by pi and
denoted Gy,pi. This generates the set { ˆGRV(Gx,Gy,pi)}pi∈Π and the p-value of an observed
GRV statistic, ˆGRV(Gx,Gy), can be obtained as the proportion of permuted statistic values
greater than or equal to ˆGRV(Gx,Gy). This is a right-tailed test as larger GRV values provide
evidence against the null.
In order to estimate the p-value without permutations, we adopt a moment matching
approach where the exact null distribution which would be obtained if all N ! permutations
were used is approximated by a continuous distribution. In particular, we approximate the
null distribution by the Pearson type III distribution, which has been shown to capture skewed
characteristics of null sampling distributions (Mielke and Berry, 2007; Josse et al., 2008). To
use this distribution we require the first few moments of the exact permutation distribution
of T ; the mean is µ = 1
N !
∑
pi∈Π Tˆpi, the variance is σ
2 = 1
N !
∑
pi∈Π Tˆ
2
pi −µ2 and the skewness is
γ =
1
N !
∑
pi∈Π Tˆ
3
pi − 3µσ2 − µ3
σ3
,
where Tˆpi = tr(GxGy,pi) and Π contains all N ! permutations. No permutations are needed
to compute {µ, σ, γ}, since closed-form expressions of these quantities are retrievable via the
analytical results of Kazi-Aoual et al. (1995). These results require that Gx and Gy are
square, symmetric and centered; properties satisfied by definition.
On obtaining closed-form expressions for the mean, variance and skewness of the exact
permutation distribution of T , we standardize T by subtracting µ and dividing by σ. The
resulting Ts = (T − µ)/σ is then assumed to have the Pearson type III distribution under
the null with probability density function (PDF) denoted fTs(t; γ); see Mielke and Berry
(2007) for the full definition of the distribution. We denote the CDF of Ts by FTs(t; γ). The
approximate null distribution of GRV(Gx,Gy) = T/||Gx||||Gy|| can then be derived by a
simple transformation of the distribution of Ts. The CDF of GRV, FGRV(x; γ), is given by
FGRV(x; γ) = FTs
(
x||Gx||||Gy|| − µ
σ
; γ
)
,
and this is a valid CDF since FTs(; γ) is a valid CDF. The p-value of an observed GRV statistic
ˆGRV(Gx,Gy) is then estimated by 1−FGRV( ˆGRV(Gx,Gy); γ). The PDF fGRV(x, γ) is found
by differentiation as
fGRV(x, γ) =
( ||Gx||||Gy||
σ
)
fTs
(
x||Gx||||Gy|| − µ
σ
; γ
)
,
since ||Gx||||Gy|| > 0 and σ > 0.
3 Power Studies
In this section we assess the power of the proposed GRV test and compare it to the classical
Mantel test. A Monte Carlo procedure is used to estimate the power of the GRV test, and
in order to estimate the power of the Mantel test we use the recently proposed algorithm of
Gandy and Rubin-Delanchy (2013). This algorithm estimates the power of a Monte Carlo
testing procedure and states a confidence interval around this estimate boasting a guaranteed
coverage probability. It also states the average number of Monte Carlo permutations required
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to achieve the given power estimate. It requires specification of the maximum length of the
resulting confidence interval and the desired coverage probability, and then runs as many
permutations as required to yield a power estimate with a confidence interval of length no
greater than specified. Using this approach we are able to demonstrate that, at least for the
experimental setups considered, many millions of permutations are needed for the Mantel
test to achieve power of the same precision as the GRV test, and that the GRV test achieves
greater power.
We use simulated data that mimics the experimental data of a typical eQTL application
where transcriptional measurements are paired with SNPs. We first generate an N×P matrix
X containing N simulated SNPs (i.e., minor allele counts), denoted xi = (xi1, . . . , xiP )
T
for i = 1, . . . , N , with varying minor allele frequencies (MAFs) at each of the P SNPs.
The MAF of SNP p, mp, is first simulated from a uniform distribution U(0.1, 0.5), and the
allele count is then simulated from a multinomial distribution with probabilities (1 −mp)2,
2mp(1−mp), andm2p of observing 0, 1 and 2 minor alleles, respectively. The paired data matrix
Y = (y1, . . . ,yN )
T is then generated as follows. The N × 1 vector z =X1P = (z1, . . . , zN )T
containing the row sums of X, i.e., the minor allele counts across the P SNPs, is computed,
and yi = zi1Q + ei for i = 1, . . . , N , where ei ∼ NQ(µ,Σ), with µ = (µ1, . . . , µQ)T and
µq ∼ U(0, 1) for q = 1, . . . , Q, and Σ a random Q × Q Wishart matrix. We then consider
the widely-used identity-by-state (IBS) distance for the simulated genetic markers in X,
which measures the degree to which alleles are shared across the SNPs (see, for instance,
Goh et al. (2011)), in addition to the Sokal and Sneath, and Rogers and Tanimoto I distances
(Selinski and Ickstadt, 2005). For the observations in Y we use the Euclidean, Manhattan
and Mahalanobis distances. See Appendix C for details on these distances.
For P = 2, Q = 10, and each of N = {30, 50, 70, 90, 100}, the power of the GRV test is
computed using 50 Monte Carlo runs, and each time generating 50 paired datasets as above.
For each genetic and gene expression distance, the GRV test is applied and the proportion
of p-values less than or equal to the significance level of 0.1% is recorded. The mean power
across all 50 Monte Carlo runs for each distance combination and value of N is reported in
Table 1, in addition to the standard deviation of these estimates. As expected, the power
increases with N .
We then estimate the power of the Mantel test for each of the above settings using the
algorithm of Gandy and Rubin-Delanchy (2013). For each setting we bound the confidence
interval length by twice the standard deviation of the corresponding estimate for the GRV
test. That is, we consider one standard deviation on either side of the power estimate as an
empirical indication of the precision achieved by the GRV test. We monitor the number of
Monte Carlo permutations required to obtain power estimates with such confidence intervals
with a coverage probability of 95%. These results are also given in Table 1, where the power
is stated alongside the confidence interval, and the number of Monte Carlo permutations
required is stated on a separate line below the confidence interval.
In all settings the GRV test achieves greater power than the Mantel test, even when using
large numbers of Monte Carlo permutations. Note that while the Mantel power estimates
improve with N , as expected, the number of Monte Carlo permutations varies between O(105)
to O(109) non-linearly with N . This is an artefact of the algorithm; the expected number
of permutations depends on the length of the confidence interval sought and the region of
the confidence interval in [0, 1] (see Gandy and Rubin-Delanchy (2013) for more details). An
example of how the standardization used by GRV yields greater power than that used by
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Mantel is presented in Appendix D, in addition to simulation results demonstrating that the
GRV test attains the nominal significance level of a given test.
4 Application to ovarian cancer
Around 225, 000 women were estimated to have developed ovarian cancer in 2008, of which
over 80% are Epithelial Ovarian Cancer (EOC). In the UK EOC has particularly poor prog-
nosis with only 34% of patients surviving 5 years after diagnosis.
In many cancers, the ability to measure some biomarker that can predict the likely re-
sponse to a chemotherapeutic agent could prevent patients unnecessarily suffering side-effects
from ineffective treatments, and may suggest the best course of action where multiple treat-
ments are available. Unfortunately, while high-throughput gene expression profiling has been
successful in identifying prognostic ‘signatures’ for many cancers (van’t Veer and Bernards,
2008), solid tumour gene expression profiles have practical drawbacks preventing their use as
prognostic or predictive biomarkers in the clinic, especially in terms of obtaining mRNA from
the tumour and the transitive nature of gene expression (Sawyers, 2008). However, circulating
tumour DNA can be isolated from serum samples in ovarian cancer patients (Hickey, 1999),
which reflect an attractive source for genetic biomarkers both because of the relative ease of
accessibility of the patient material and the long-term stability of the genetic sequence. Addi-
tionally, treating biological pathways as multidimensional biomarkers may provide substantial
improvements in terms of robustness over single agents (Dai et al., 2011).
We sought to discover if it might be possible to use genetic biomarkers as surrogates for the
transcriptional activation of pathways. Such pathway-based genetic biomarkers may suggest
starting points for the development of clinical diagnostic tests to predict the outcome of a
therapeutic exploiting a related pathway.
In order to identify pathways for which the profile of SNP genotypes across genes in the
pathway closely reflects the state of expression of the genes in the pathway, we applied the
GRV test to evaluate the significance of the degree of similarity in distance matrices derived
from SNP genotypes and gene expression levels from a large set of selected pathways, for two
independent cohorts.
4.1 Datasets
For this study we use two independent cohorts of ovarian cancer patients: one collected by the
TCGA consortium, and an independent cohort for validation. For the TCGA cohort, raw data
CEL files from Affymetrix SNP 6.0 and from Affymetrix HT-HGU133A microarray profiling
499 primary high grade serous ovarian tumours were obtained from the TCGA web reposi-
tory. For the Affymetrix SNP 6.0 arrays, normalization and genotype calling were performed
using the CRLMM method (Carvalho et al., 2007). Current annotations were obtained from
Affymetrix’s NetAffx Analysis Center and SNPs were annotated with their associated Gene
Symbols. Once SNP probes were mapped to Gene Symbols, lists of SNPs corresponding to
each CPDB pathway were obtained by selecting all SNP probes mapping to Gene Symbols
that were included in the pathway’s list of hgnc symbol ids as downloaded from Consensus-
PathDB (CPDB) (Kamburov et al., 2011). For the Affymetrix HT-HGU133A arrays, data
normalization was performed using the RMA method (Irizarry et al., 2003). Probe-set map-
ping to Gene Symbols was performed using the hthgu133a.db package from Bioconductor.
Once probe-sets were mapped to Gene Symbols, lists of probe-sets corresponding to each
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CPDB pathway were obtained by selecting all probe-sets mapping to Gene Symbols that
were included in the pathway’s list of hgnc symbol ids as downloaded from CPDB.
As an independent validation data set, raw data CEL files from both Affymetrix SNP
6.0 and Affymetrix HGU133plus2 microarrays profiling 60 primary high grade serous ovarian
tumours were obtained from the Hammersmith Biobank Resource Centre. The datasets were
provided courtesy of the Genome Institute of Singapore. Raw data for this independent
tumour cohort was processed identically to those obtained from TCGA, although mapping of
gene expression probe-sets to Gene Symbols was performed using the hgu133plus2.db package
from Bioconductor. The tables of genotype calls and normalized gene expression values,
mapped to pathways which were used in this analysis, are provided in Supplementary Tables
S1 and S2, respectively.
We wanted to reduce the possibility that any identified associations simply reflected
genome-wide similarity structures between the patients (e.g. due to molecular subtypes of
disease) or involved so few measurements that they weren’t indicative of the entire pathway.
From the full list of 4, 119 CPDB pathways we filtered out all those with less than 5 or more
than 200 probe sets in either gene expression or SNP genotype array datasets. A total of 479
pathways remained after this filtering, and these pathways are listed in Supplementary Table
S3 along with their mappings to probes in each of the two datasets.
4.2 Experimental results
Since different distance measures highlight different relationships among genetic markers and
features of gene expression data (Priness et al., 2007; Song et al., 2012), we sought to per-
form a meta-analysis to combine the results of similarity testing across a range of distance
measures for both the genotypes and gene expression values. The rationale being that if a
given pathway shows similar distance matrices at the genotype and gene expression level for a
number of different distance measures, the observed similarity is unlikely to be due to a quirk
of one particular distance measure. For each of the 479 pathways, sample-wise distance matri-
ces were calculated using 8 different distance measures (Euclidean, Mahalanobis, Manhattan,
Maximum, Bray-Curtis, Pearson’s correlation, Spearman’s correlation and Cosine angle dis-
tances) for the gene expression data and 5 distance measures (IBS, SS, RTI, Simple Matching
and Hamman I) for the SNP genotypes; see Appendix C for details on these distances. The
association between the paired distance matrices, one derived from the genotypes of SNPs
mapping to genes in the pathway and the other derived from the expression levels of genes in
the pathway, was evaluated using the GRV test. This resulted in 40 individual p-values for
each pathway, one for each combination of distance measures used. An illustration of how
the the null distribution compares with the permutation distribution when applied to this
cancer data is presented in Appendix E. The 40 individual p-values for each pathway were
then combined using the ‘maximum’ method as implemented in the R package MetaDE. The
combined significance estimates from running this meta-analysis for each pathway are given
in Supplementary Table S4. This meta-analysis was then repeated for the validation cohort.
To obtain a perspective of the robustness/repeatability of the associations detected be-
tween genotype and gene expression at the pathway level across the two independent cohorts,
we compared the ranked lists of pathways arising from the meta-analysis of each cohort.
The degree of agreement between the two ranked lists was evaluated using the normalized
Canberra distance (Jurman et al., 2008). The general principle is to quantify the distance
between the rankings of the top k terms of two ranked lists, with each term’s influence on the
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overall distance weighted by its position in its respective list. By evaluating the normalized
Canberra distance for the top-ranked k pathways, the relationship between overlap and rank-
ing can be explored: smaller values indicate a lesser discrepancy in rankings among the top
k terms and therefore more similar rankings in the two lists. Figure 1 shows the normalized
Canberra distance plotted against k.
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Figure 1: Plot of the normalized Canberra distance against k for the top k elements in two lists of
pathways. Each pathway list is ranked according to meta-analysis estimate of significance of association
between genotype and gene expression over 40 combinations of distance measures, one ranked list per
cohort. The dotted line represents the average normalized Canberra distance between the TCGA
data-derived pathway list and each of 5, 000 random permutations of the ranks in the second list.
It can be seen that the overlap of the meta-analysis results from the two cohorts is greatest
for small k, implying that the highest-ranking pathways in each list are more similar than
the lower-ranking pathways. Furthermore, for each k we used 5, 000 permutations of the
ranks in the second list to obtain a p-value estimate for the normalized Canberra distance
values observed between the two rankings. These p-values across the range of k were less
than 0.005 after false discovery rate multiple-testing adjustment, reflecting the fact that the
overlap between the two ranked lists of pathways was significantly greater than that expected
by chance. These results suggest that the association between distance matrices based on
the levels of expression of genes within certain pathways and distance matrices based on
SNP genotypes associated with genes in the corresponding pathways is robust and reliably
evaluated by the GRV test. The meta-analysis of the GRV test result across multiple distance
measures demonstrates that these associations are not a result of peculiarities of particular
distance measures, and certain pathways are shown to exhibit a very strong association in
both cohorts.
A particularly striking result of this study is the CPDB pathway ‘5-aminoimidazole ri-
bonucleotide biosynthesis’, which is ranked #1 in the meta-analysis of GRV test results from
the TCGA dataset and ranked #2 in the meta-analysis of GRV test results from the validation
dataset. The 5-aminoimidazole ribonucleotide is a precursor to de novo purine biosynthesis,
which is essential for rapidy proliferating tissue (Firestine and Davisson, 1993). Pharmaco-
logical inhibition of de novo purine biosynthesis has proved to be a successful strategy in the
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clinic for treating cancers and inflammatory disorders (Christopherson et al., 2002). It has
been shown through a clinical trial that genetic polymorphisms could be biomarkers to pre-
dict response to methotrexate therapy, which inhibits de novo purine biosynthesis, in patients
with rheumatoid arthritis (Dervieux et al., 2004). The ‘methotrexate pathway’ itself showed
significant genotype-expression association in the TCGA cohort (ranked #17), but not in the
validation cohort (ranked #316). The ‘5-aminoimidazole ribonucleotide biosynthesis’ path-
way may therefore suggest additional or alternative SNPs to use as genetic biomarkers for
predicting outcome of inhibiting de novo purine biosynthesis.
Another result of note is that the CPDB pathway Platinum Pathway, Pharmacokinet-
ics/Pharmacodynamics yields highly significantly similar tumour-wise distance matrices across
all 40 applications of the GRV test on this paired ovarian cancer data, for both cohorts inves-
tigated (ranked #14 from the TCGA dataset and #42 from the validation dataset). This is
particularly interesting because platinum-based chemotherapy is the standard treatment for
ovarian cancer, but unlike for many other solid cancers, survival rates in ovarian cancer have
not improved noticeably in the 30 years since this treatment was introduced (Vaughan et al.,
2011). The principal reason for this is the high frequency of platinum-resistant relapse, which
may occur through multiple mechanisms (Agarwal and Kaye, 2003; Stronach et al., 2011).
Therefore, being able to predict the response to the platinum-based DNA damaging agents
could be of great clinical value in the treatment of ovarian cancer. Additionally, all genotype-
derived and expression-derived distance matrices for the Base Excision Repair pathway are
highly significantly similar in the TCGA cohort. This is of interest as the Base Excision
Repair pathway is involved in repairing platinum-induced DNA damage. In fact, effective
inhibition of this pathway (via PARP) in patients with BRCA1/2 mutations is associated
with sensitivity to platinum chemotherapy (Fong et al., 2010).
5 Conclusion
In this work we have presented the GRV test as a novel procedure to detect association
between paired distance matrices, which is applicable in any setting where suitable distance
measures can be defined. Similarly to the widely used Mantel test, the GRV test can be
directly applied whether the distance measures are metric or semi-metric, but overcomes the
limitation of the Mantel test that, where paired data is vector-valued, a hypothesis of no
correlation between the vectors of interest can be tested. As a further advantage of the GRV
test over existing distance-based tests, an approximate null distribution is proposed such
that inference can be performed without expensive Monte Carlo permutation procedures.
Through extensive simulations we have demonstrated that the GRV test achieves greater
power than the popular Mantel test. This greater power is exhibited even when many millions
of permutations are used for the Mantel test, thus demonstrating its suitability as a tool for
use in multiple-testing settings were many tests need to be simultaneously performed.
The GRV test was applied to paired ovarian cancer datasets in which genome-wide pro-
files of SNP genotypes and gene expression levels were available for each patient across two
independent cohorts (N = 499 and N = 60). The paired datasets were split into subsets
in which the features all mapped to the same pathway (using mappings from the Consensus
Pathway DB), so that each GRV test result would indicate the statistical significance of the
similarity between the (tumour-wise) distance matrix derived from the genotype data and the
distance matrix derived from the gene expression data. For each cohort a meta-analysis was
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performed across the GRV test results from 40 different combinations of distance measures,
and the pathways were ranked according to their significance across all distance measures.
Permutation-based estimates of the significance of the overlap between the ranked lists of
pathways from the two independent cohorts revealed a highly significant agreement in the
two rankings, indicating a degree of robustness in the results of our analysis.
This application of the GRV test has demonstrated that the transcriptional activity of a
number of pathways seem to be reliably predicted by sequencing a limited set of genetic mark-
ers that could be detected in circulating tumour DNA obtained from patients’ serum. This
relationship was particularly pronounced for the pathway ‘5-aminoimidazole ribonucleotide
biosynthesis’, for which the genotypes and the gene expression patterns were strikingly as-
sociated in two independent cohorts of patients. The association between genotypes and
pathway-level gene expression profile is of particular interest in the case of the platinum re-
sponse pathway, which is clearly clinically important in EOC given that the only standard
treatment involves platinum-based chemotherapy. Following further investigation, these ob-
servations could potentially lead to development of non-invasive biomarkers that could predict
patient response to front-line chemotherapy, and serve to stratify patients for selection into
clinical trials involving alternative treatments.
As individual distance measures can yield different results in the analysis of associations
across gene expression patterns, unless a single distance measure is selected a priori as the
most appropriate for each dataset, combining results of multiple tests of association using
different distance measures may provide more reliable results than a single test. A key ad-
vantage of the GRV test in our application to multivariate eQTL mapping of pathways in
ovarian cancer is that it enables a meta-analysis of the associations between genetic distance
and gene expression distance for different combinations of distance measures. Having a test
for these associations that does not require expensive permutations enables a fast estimation
of the robustness of the genotype-expression pathway level associations against quirks of par-
ticular definitions of distance. Given the robust associations discovered in this analysis, we
suggest that it may be possible to predict the mode of activation of a pathway (in terms of
which members are transcriptionally activated) in cancer patients, based on the genotype of
the tumours’ DNA across a limited panel of SNPs.
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A GRV statistic is a correlation coefficient
Consider the quantity cor(gx,gy). To compute this we require the mean and standard devi-
ation of the values in gx and gy. The means are 0 since Gx and Gy are centered matrices.
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The standard deviation of the elements in gx is given by√√√√ 1
N2 − 1
N∑
i=1
N∑
j=1
(
gx(xi, xj)
||Gx||
)2
=
√√√√ 1
||Gx||2 (N2 − 1)
N∑
i=1
N∑
j=1
g2x(xi, xj)
=
√
||Gx||2
||Gx||2 (N2 − 1)
=
√
1
N2 − 1 ,
and similarly for gy. Thus the correlation of interest is given by
cor (gx,gy) =
1
N2 − 1
N∑
i=1
N∑
j=1

gx(xi, xj)/|Gx||√
1
N2−1



gy(yi, yj)/||Gy||√
1
N2−1


=
1
N2 − 1
1(
1
N2−1
) N∑
i=1
N∑
j=1
gx(xi, xj)gy(yi, yj)
||Gx||||Gy||
=
1
||Gx||||Gy||
N∑
i=1
N∑
j=1
gx(xi, xj)gy(yi, yj)
=
tr (GxGy)
||Gx|| ||Gy||
= GRV(Gx,Gy),
as required.
B Properties of the GRV statistic
The interpretation of GRV as a correlation coefficient indicates that it may range between
−1 and 1, with negative values indicating association in the form of a linear correlation of
different sign (as with Pearson’s correlation and Mantel). In this section we discuss how to
interpret the values of GRV.
To begin, we show that the GRV statistic is related to the Frobenius distance between
Gx and Gy. Recall that the Frobenius distance between two matrices A and B of equal
dimensions is defined by dF (A,B) =
√
tr ((A−B)T (A−B)). It is easily shown that the
Frobenius distance between the scale invariant configurations Gx/||Gx|| and Gy/||Gy|| is
related to the GRV statistic by
dF
(
Gx
||Gx|| ,
Gy
||Gy||
)
=
√
2 (1−GRV(Gx,Gy)). (4)
When dF (Gx/||Gx||,Gy/||Gy||) = 0, observe that perfect association is achieved when
GRV(Gx,Gy) = 1, i.e., when
Gx
||Gx|| =
Gy
||Gy|| . (5)
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This equality, however, can only be attained if Gx and Gy are both positive semi-definite
(having non-negative diagonals), or both indefinite (having non-negative and negative values
on the diagonals). These occur if dx and dy are both metric, or semi-metric, respectively.
When one distance function is metric and the other is semi-metric, perfect association cannot
be attained, as the diagonals of Gx and Gy cannot be equal. In addition, negative values are
attained for GRV for certain combinations of these metric properties.
To see this, consider the upper and lower bounds of the GRV statistic, found as follows.
Let the ordered eigenvalues of Gx and Gy be denoted {λx,i}Ni=1 and {λy,i}Ni=1, respectively,
and consider the bounds of the quantity tr (GxGy). Using the result of Lasserre (1995), which
gives bounds for the trace of the product of two Hermitian matrices (square, complex-valued,
and equal to their conjugate transpose), these are given by
N∑
i=1
λx,iλy,N−i+1 ≤ tr(GxGy) ≤
N∑
i=1
λx,iλy,i.
The bounds for GRV are then given by∑N
i=1 λx,iλy,N−i+1
||Gx||||Gy|| ≤ GRV(Gx,Gy) ≤
∑N
i=1 λx,iλy,i
||Gx||||Gy|| ,
since ||Gx||||Gy|| > 0. The numerators of the bounds of GRV are sums of eigenvalue products,
and so may be non-negative or negative depending on the sign of the eigenvalues. This in
turn depends on the distance functions satisfying the metric property; they are either both
metric or both semi-metric, or one is metric and the other is semi-metric. Note that greater
Frobenius distance values occur with lower GRV values which may be negative, and so the
paired distance matrices are considered to be less associated.
B.1 Both metric or semi-metric distances
When the distances are both metric, Gx and Gy are positive semi-definite and the ordered
eigenvalues {λx,i}Ni=1 and {λy,i}Ni=1 are non-negative (Krzanowski, 2000). The summation in
the lower bound contains the terms {λx,iλy,N−i+1}Ni=1, which are therefore non-negative, so
that GRV is non-negative. The minimum value of 0 indicating no association is attained
when tr (GxGy) = 0. This can be interpreted in terms of the N × N principal coordinate
matrices arising from ∆x and ∆y, denoted X˜ and Y˜ , respectively. These matrices are found
by classical multidimensional scaling (MDS) such that the rows are N -dimensional represen-
tations of the original observations in Euclidean space, and their pairwise Euclidean distances
equal the corresponding pairwise distances in ∆x and ∆y (Torgerson, 1952; Gower, 1966).
It then follows that Gx = X˜X˜
T and Gy = Y˜ Y˜
T , so that tr (GxGy) = tr(X˜X˜
T Y˜ Y˜ T ) =
0 ⇒ X˜T Y˜ = 0, i.e., the principal coordinate matrices are orthogonal. The maximum value
GRV can take is 1, since Gx and Gy have positive diagonal elements so that equality (5) can
be attained. In this case the distance matrices are equal up to a positive scaling factor, and
there is perfect association.
Note also that when X and Y are centered vector-valued observations with XTY = 0,
and dx and dy are the Euclidean distance functions, GRV yields a value of 0. This is because
X˜X˜T = XXT and Y˜ Y˜ T = Y Y T , so that tr (GxGy) = tr(X˜X˜
T Y˜ Y˜ T ) = tr
(
XXTY Y T
)
.
This result applies when the data is scalar-valued, so GRV equals 0 inline with the raw data
being uncorrelated. Thus GRV overcomes the limitation of Mantel.
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On the other hand, when the distances functions are both semi-metric, the ordered eigen-
values {λx,i}Ni=1 and {λy,i}Ni=1 are both non-negative and negative, so that GRV may attain
negative values. Since the diagonal elements of Gx and Gy are both positive and negative,
there may exist two such matrices with equal diagonals. Hence there may exist a scenario in
which equality (5) is attained, and perfect association is indicated by a GRV value of 1.
B.2 Metric and semi-metric distances
When one of the distances, dx for instance, is metric while dy is semi-metric, then only the
ordered eigenvalues {λx,i}Ni=1 are strictly non-negative, so that the summation in the lower
bound may be negative. In this case, GRV may attain negative values. The maximum
attainable value of GRV is not 1 in this case, since equality (5) cannot be attained. This
is because the diagonals of Gx are positive while the diagonals of Gy are both positive and
negative. Thus perfect association cannot be attained, but larger values indicate greater
association.
This result is not surprising because the relationship between pairwise distances with
respect to dx and dy cannot be the same. Recall that metric distance functions satisfy the
triangle inequality so that dx(xi, xj) ≤ dx(xi, xk) + dx(xk, xj) for any three observations
xi, xj , xk (Mardia et al., 1979). The corresponding distances with respect to dy will not share
this property as dy is semi-metric, that is, dy(yi, yj) does not satisfy dy(yi, yj) ≤ dy(yi, yk) +
dy(yk, yj) for yi, yj, yk. Thus the inter-point relationships between all the distances in ∆x will
not match those in ∆y (for if they did dy would satisfy the triangle inequality and hence be
metric).
C Distance measures
C.1 SNPs
Assume two P -dimensional vectors x = (x1, . . . , xP )
T and y = (y1, . . . , yP )
T with discrete-
valued elements representing minor allele counts at P SNPs. The identity-by-state (IBS)
distance measure is defined as
dIBS(x,y) = 1− 1
2P
P∑
p=1
s(xp, yp),
where s(xp, yp) = 0 if xp = 0 and yp = 2, or if xp = 2 and yp = 0, s(xp, yp) = 1 if xp = 1
and yp 6= 1, or if yp = 1 and xp 6= 1, and s(xp, yp) = 2 if xp = yp. This distance takes values
between 0 and 1 and is semi-metric.
Genetic distances have also been proposed based on the contingency table containing the
frequency that each combination of minor allele counts occurs over the SNPs (Selinski and Ickstadt,
2005); see Table 2.
The key statistics in this table are the number of complete matches of the minor allele
counts, m+ =
∑2
k=0mkk, and the number of mismatches, m
− = P−m+, where the total num-
ber of possible matches is P . Based on these quantities, the following ‘matching coefficient’
distance measures can be defined; the Simple Matching distance
dSM (x,y) = 1− m
+
P
,
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Table 2: Contingency table containing the frequency of a given combination of minor allele count
between x and y over the P SNPs. mkl is the frequency of x having k minor alleles and y having l
minor alleles.
❍
❍
❍
❍
❍❍
x
y
0 1 2
0 m00 m01 m02
1 m10 m11 m12
2 m20 m21 m22
the Sokal and Sneath (SS) distance
dSS(x,y) = 1− m
+
m+ + 1
2
m−
,
and the Rogers and Tanimoto I (RTI) distance
dRTI(x,y) = 1− m
+
m+ + 2m−
.
There is also the Hamman I similarity measure
sHI(x,y) =
m+ −m−
P
,
which can be transformed into a distance measure as follows. Assume N P -dimensional
minor allele count vectors {xi}Ni=1; this is required in order to normalize the magnitude of the
similarities to the range [0, 1]. The Hamman I distance between xi and xj is then given by
dHI(xi,xj) = 1− s
∗(xi,xj)
max
i,j
{s∗(xi,xj)} ,
where s∗(xi,xj) = sHI(xi,xj) + |min
i,j
{sHI(xi,xj)}|. This takes values between 0 and 1 and
is semi-metric.
C.2 Vectors
Assume two P -dimensional real-valued vectors x = (x1, . . . , xP )
T and y = (y1, . . . , yP )
T .
Many measures exist (see, for example, Pekalska and Duin (2005)), of which a few are pro-
vided in Table 3, along with their ranges and properties, i.e., whether they are metric or
semi-metric. These include the Euclidean, Manhattan, Maximum, Bray-Curtis, Pearson’s
correlation and the Cosine angle distances.
Spearman’s correlation distance is defined by applying Pearson’s correlation to the ranks
of the elements of the vectors, rather than the actual values. In particular, let xr =
(xr1, . . . , xrP )
T and yr = (yr1, . . . , yrP )
T be the vectors containing the ranks of the elements
of x and y, respectively in ascending order (highest value given rank 1). That is, xrp is the
rank of xp, and similarly for yrp. If several elements of a given vector are equal, they are
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Table 3: Commonly encountered distance measures for vector-valued objects. The (M) or (SM) by
each distance name indicates whether it is metric or semi-metric.
Distance Notation Definition Range
Euclidean (M) dE(x,y)
√
(x− y)T (x− y) [0,∞)
Manhattan (SM) dMAN (x,y)
∑P
p=1 |xp − yp| [0,∞)
Maximum (SM) dMAX(x,y) max
p
{|xp − yp|} [0,∞)
Bray-Curtis (SM) dBC(x,y)
∑P
p=1 |xp − yp|∑P
p=1 (xp + yp)
[0,∞)
Mahalanobis (SM) dMAH(x,y)
√
(x− y)T S−1 (x− y),
S a P × P covariance matrix, P < N
[0,∞)
Pearson’s
correlation (SM)
dPC(x,y) 1−
∑P
p=1 (xp − x¯) (yp − y¯)∑P
p=1 (xp − x¯)2
∑P
p=1 (yp − y¯)2
, [0, 2]
x¯ = 1
P
∑P
p=1 xp, y¯ =
1
P
∑P
p=1 yp
Cosine
angle (SM)
dPC(x,y) 1− x
Ty
||x|| ||y|| , [0, 2]
||x|| =
√∑P
p=1 x
2
p, ||y|| =
√∑P
p=1 y
2
p
assigned a rank equal to the mean of their respective positions in the list of ascending values.
For example, for vector (0.1, 0.4, 0.4, 0.5,−31)T , their respective positions are (4, 3, 2, 1, 5)T
or (4, 2, 3, 1, 5)T , so that the ranks are given by (4, 2.5, 2.5, 1, 5)T . Spearman’s correlation
distance between x and y is thus given by
dSC(x,y) = dPC(xr,yr),
which ranges between 0 and 2 and is semi-metric.
The normalized mutual information (NMI) distance is defined as follows. The P elements
of x and y are considered to be observations of the random variables x and y, respectively.
Let px(·) denote the PMF of x found by considering the histogram of the elements of x with
M bins. That is, px(i) gives the proportion of the elements {xp}Pp=1 in the ith bin. We follow
Priness et al. (2007) and use the integer value of
√
P as M . Estimate the entropy of x by
E(x) = −
M∑
m=1
px(m)log (px(m)) ,
and similarly for y with PMF py(·). Estimate the joint entropy of x and y by considering
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the joint PMF, denoted {pxy(i, j)}Mi,j=1, using a two-dimensional histogram of x and y, as
E(x, y) = −
M∑
m=1
M∑
n=1
pxy(m,n)log (pxy(m,n)) .
The NMI distance measure is then given by
dNMI(x,y) = 1− E(x) + E(y)− E(x, y)
max {E(x),E(y)} ,
where the fraction is the NMI (Michaels et al., 1998). This distance is bounded by 0 and 1
and is semi-metric.
D Simulation results
D.1 Comparison between GRV and Mantel
Since the GRV and Mantel statistics can both be expressed as correlation coefficients, the
difference in performance is due to the difference in standardized distance elements used as
inputs in each case; a classical standardization is applied to the upper-triangular distance
elements by Mantel, and a normalized double-centering is applied to the complete distance
matrix by GRV. Figure 2 demonstrates that, for the data simulated as described in Section 3
of the article with N = 50 and with the IBS and Mahalanobis distances, the standardization
used by GRV yields a stronger correlation than the standardization used by Mantel. This is
an example of how the standardization used by GRV better detects the association inherent
in the simulated data.
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Figure 2: Standardized and normalized double-centered distances (gray points) used by the Mantel
and GRV statistics, for the IBS and Mahalanobis distances for N = 50. In each case the gradient of
the black line equals the correlation and hence the statistic value. The standardization used by GRV
yields a higher correlation than achieved by the standardization used by Mantel.
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Table 4: Mean (and standard deviation) of the proportion of null p-values less than or equal to the
given significance levels for N = {30, 50, 70}.
Significance level (%)
N 1 5 10
30 0.010 (0.007) 0.051 (0.014) 0.100 (0.020)
50 0.010 (0.006) 0.050 (0.016) 0.101 (0.020)
70 0.011 (0.006) 0.051 (0.017) 0.102 (0.021)
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Figure 3: Sampling distributions of the GRV statistic obtained using 106 Monte Carlo permutations
and the proposed approximate PDF applied to a pathway of the real data including a SNP-set com-
prised of 2092 SNPs and a transcript-set comprised of 51 transcripts. (a) The IBS distance is applied
to the SNP data and the Mahalanobis (Mah) distance is applied to the gene expression data. (b) The
SS distance is applied to the SNP data and the Pearson’s correlation distance (PC) distance is applied
to the gene expression data. (b) The RTI distance is applied to the SNP data and the normalized
mutual information (NMI) distance is applied to the gene expression data.
D.2 Attainment of nominal significance level of GRV
We demonstrate that the GRV test attains the nominal significance level of a given test for
a range of significance levels by using a Monte Carlo procedure. We generate paired data
inspired by the eQTL application setting used in the power study.
For 100 Monte Carlo runs, 200 paired datasets are generated as described in Section 3 of
the article for P = 2, Q = 10, and N = {30, 50, 70}, except with yi = ei so that yi is not
dependent on xi, and the IBS and Mahalanobis distance measures applied. Over all runs the
mean and standard deviation of the proportion of p-values less than or equal to significance
levels of 1%, 5%, 10% are monitored. These are presented in Table 4, where it is clear that
the nominal significance levels are attained.
E Illustration of the null distribution of GRV for real data
In order to illustrate how the null distribution compares with the permutation distribution
when applied to real data, we consider a subset of the cancer data. For a SNP-set comprised
20
of 2092 SNPs and a transcript-set comprised of 51 transcripts, each of the following combi-
nations of SNP and gene expression distances were applied: (a) IBS and Mahalanobis, (b)
SS and Pearson’s correlation, and (c) RTI and normalized mutual information. For each we
obtained the approximate null distribution of the GRV statistic and the permutation distri-
bution using 106 Monte Carlo permutations. These are given in Figure 3, where we see that
the approximate distribution appears to provide a good fit to the permutation distributions.
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